Randomized trial · people

Exenatide: lower intracranial pressure in IIH over 12 weeks

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In a small early trial, exenatide lowered skull pressure in women with IIH within hours, and the drop held through 12 weeks.

Kind
Randomized trial
Studied in
People
Number studied
16
Published
2023
Journal
Brain

What they tested

The team tested whether exenatide lowers pressure inside the skull in women with idiopathic intracranial hypertension (IIH, raised skull pressure with no known cause).

How the study was done

A randomized, placebo-controlled, double-blind trial in 16 adult women with active IIH, defined as pressure above 25 cmCSF (a unit of skull pressure) plus papilledema (swelling at the back of the eye), given exenatide or placebo (a dummy shot) under the skin. Implanted sensors tracked skull pressure over time, and 15 women finished the 12-week study.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking exenatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

At the start, the women averaged 28 ± 9 years of age, a body mass index of 38.1 ± 6.2 kg/m2 and a skull pressure of 30.6 ± 5.1 cmCSF. Exenatide lowered skull pressure by -5.7 ± 2.9 cmCSF at 2.5 hours (P = 0.048), -6.4 ± 2.9 cmCSF at 24 hours (P = 0.030) and -5.6 ± 3.0 cmCSF at 12 weeks (P = 0.058). The trial set its threshold for a significant result at a P value under 0.1, chosen before it began. No serious safety signals were seen.

What it doesn’t show

This was a very small trial of 16 women, 15 of whom finished, and it lasted 12 weeks. It included only adult women with active IIH, and the team saw the results as a reason to move on to a phase 3 trial.

The paper

Mitchell et al. The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial. Brain. 2023.

The compound

More studies on Exenatide

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking exenatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo